Publication de 4 numéros par an
ISSN Imprimer: 0731-8898
ISSN En ligne: 2162-6537
Indexed in
10H-3,6-Diazaphenothiazine-Induced, Caspases-Mediated Mitochondrial-Dependent Apoptosis on HepG2 Hepatocellular Carcinoma Cells and Suppressed Cancer Cells Invasion via Inhibiting Mitochondrial Thioredoxin Reductase Enzymatic Activities
RÉSUMÉ
Early development of liver cancer is usually asymptomatic. The overall survival rate of patients is relatively low due to late diagnosis, despite hepatocellular carcinoma being a common diagnosis. The high mortality rate of liver cancer was due to its overactivated cellular mitochondrial activities, namely thioredoxin reductase enzymatic activities and its downstream activation of nuclear factor kappa B (NF-κB) signaling pathways for cancer cell migration. Our previous study on this candidate compound on A2780 ovarian cancer cells and MCF-7 breast cancer cells, through modulation of cell-cycle checkpoints and respective targeted apoptosis pathways. The current study used HepG2 hepatocellular carcinoma cell lines as a representative in vitro liver cancer cell model. The half maximal inhibitory concentration (IC50) value was obtained via incubation of PTZ compound for 24 h yield of 37.03 μM, whereby it was three-fold more potent than the standard control tested, cisplatin (109.23 μM). The subsequent application of IC50 dosage of PTZ onto HepG2 cells illustrated a growth-static effect via activation of S-phase cell-cycle checkpoints, immediately followed by regulation of apoptosis. Increased cellular concentration of reactive oxygen species eventually generated oxidative damages on mitochondria, hence resulting in the release of cytochrome c protein and suppression of TrxR enzymatic activity, in conjunction with the suppression on invasion of cancer cells via Matrigel invasion chamber. In conclusion, PTZ was hypothesized to act effectively on mitochondria of HepG2 cells; hence it should proceed into detailed drug targeting mechanism research.
-
Nielsen KO, Mirza AH, Kaur S, Jacobsen KS, Winther TN, Glebe D, Pociot F, Hogh B, Sterling J. Hepatitis B virus suppresses the secretion of insulin-like growth factor binding protein 1 to facilitate anti-apoptotic IGF-1 effects in HepG2 cells. Exp Cell Res. 2018 Sep 15;370(2):399-408.
-
Abdel-Hamid M, Nada OH, Ellakwa DE, Ahmed LK. Role of myeloperoxidase in hepatitis C virus related hepatocellular carcinoma. Meta Gene. 2018 Dec 1;18:1-8.
-
Andersson TM, Engholm G, Pukkala E, Stenbeck M, Tryggvadottir L, Storm H, Weiderpass E. Avoidable cancers in the Nordic countries-the impact of alcohol consumption. Eur J Cancer. 2018 Nov 1;103:299-307.
-
O'Rourke JM, Sagar VM, Shah T, Shetty S. Carcinogenesis on the background of liver fibrosis: implications for the management of hepatocellular cancer. World J Gastroenterol. 2018 Oct 21;24(39):4436.
-
Liu T, Yang H, Fan W, Tu J, Li TW, Wang J, Shen H, Yang J, Xiong T, Steggerda J, Liu Z. Mechanisms of MAFG dysregulation in cholestatic liver injury and development of liver cancer. Gastroenterology. 2018 Aug 1;155(2):557-71.
-
Lei H, Wang G, Zhang J, Han Q. Inhibiting TrxR suppresses liver cancer by inducing apoptosis and eliciting potent antitumor immunity. Oncol Rep. 2018 Dec 1;40(6):3447-57.
-
Tian D, Shi Y, Chen D, Liu Q, Fan F. The Wnt inhibitor LGK-974 enhances radiosensitivity of HepG2 cells by modulating Nrf2 signaling. Int J Oncol. 2017 Aug 1;51(2):545-54.
-
Zheng Y, Song Y, Han Q, Liu W, Xu J, Yu Z, Zhang R, Li N. Intestinal epithelial cell-specific IGF1 promotes the expansion of intestinal stem cells during epithelial regeneration and functions on the intestinal immune homeostasis. Am J Physiol Endocrinol Metab. 2018 May 21;315(4):E638-49.
-
Zeng H, Lu B, Zamponi R, Yang Z, Wetzel K, Loureiro J, Mohammadi S, Beibel M, Bergling S, Reece-Hoyes J, Russ C. mTORC1 signaling suppresses Wnt/p-catenin signaling through DVL-dependent regulation of Wnt receptor FZD level. Proc Natl Acad Sci USA. 2018 Oct 30;115(44):E10362-9.
-
Petersen MC, Shulman GI. Mechanisms of insulin action and insulin resistance. Physiol Rev. 2018 Aug 1;98(4):2133-223.
-
Lu H, Han M, Yuan X, Tursun K, Zhang Y, Li Y, Li Z, Feng S, Zhou L, Pan Z, Wang Q. Role of IL-6-mediated expression of NS5ATP9 in autophagy of liver cancer cells. J Cell Physiol. 2018 Dec;233(12):9312-9.
-
Wudtiwai B, Pitchakarn P, Banjerdpongchai R. Alpha-mangostin, an active compound in Garcinia mangostana, abrogates anoikis-resistance in human hepatocellular carcinoma cells. Toxicol In Vitro. 2018 Dec 1;53:222-32.
-
Yang Y, Bae WK, Lee JY, Choi YJ, Lee KH, Park MS, Yu YH, Park SY, Zhou R, Tas I, Gamage C. Potassium usnate, a water-soluble usnic acid salt, shows enhanced bioavailability and inhibits invasion and metastasis in colorectal cancer. Sci Rep. 2018 Nov 2;8(1):16234.
-
Qiu B, Wei W, Zhu J, Fu G, Lu D. EMT induced by loss of LKB1 promotes migration and invasion of liver cancer cells through ZEB1induced YAP signaling. Oncol Lett. 2018 Nov 1;16(5):6465-71.
-
Zhang R, Niu Y, Zhou Y. Increase the cisplatin cytotoxicity and cisplatin-induced DNA damage in HepG2 cells by XRCC1 abrogation related mechanisms. Toxicol Lett. 2010 Feb 1;192(2):108-14.
-
Morak-Mlodawska B, Pluta K, Latocha M, Jelen M. Synthesis, spectroscopic characterization, and anticanceractivity of new 10-substituted 1, 6-diazaphenothiazines. Med Chem Res. 2016 Nov 1;25(11):2425-33.
-
Morak-Mlodawska B, Pluta K, Latocha M, Suwinska K, Jelen M, Kusmierz D. 3, 6-Diazaphenothiazines as potential lead molecules-synthesis, characterization and anticancer activity. J Enzyme Inhib Med Chem. 2016 Nov 1;31(6):1512-9.
-
Mucksavage P. Ureteral stents, nephrostomy tubes, and urethral dilators. In: Clinical application of urologic catheters, devices and products. Cham, Switzerland: Springer; 2018. p. 105-132.
-
He L, Ji S, Lai H, Chen T. Selenadiazole derivatives as theranostic agents for simultaneous cancer chemo-/radiotherapy by targeting thioredoxin reductase. J Mater Chem B. 2015;3(42):8383-93.
-
Arora S, Heyza J, Chalfin E, Ruch R, Patrick S. Gap junction intercellular communication positively regulates cisplatin toxicity by inducing DNA damage through bystander signaling. Cancers. 2018 Oct;10(10):368.
-
Boot A, Huang MN, Ng AW, Ho SC, Lim JQ, Kawakami Y, Chayama K, Teh BT, Nakagawa H, Rozen SG. In-depth characterization of the cisplatin mutational signature in human cell lines and in esophageal and liver tumors. Genome Res. 2018 May 1;28(5):654-65.
-
Naves MA, Graminha AE, Vegas LC, Luna-Dulcey L, Honorato J, Menezes AC, Batista AA, Cominetti MR. Transport of the ruthenium complex [Ru (GA)(dppe) 2] PF6 into triple-negative breast cancer cells is facilitated by transferrin receptors. Mol Pharm. 2019 Mar 1;16(3):1167-1183.
-
Kalainayakan SP, FitzGerald KE, Konduri PC, Vidal C, Zhang L. Essential roles of mitochondrial and heme function in lung cancer bioenergetics and tumorigenesis. Cell Biosci. 2018 Dec;8(1):56.
-
Nayak A, Kapur A, Barroilhet L, Patankar M. Oxidative phosphorylation: a target for novel therapeutic strategies against ovarian cancer. Cancers. 2018 Sep;10(9):337.
-
Gandhirajan RK, Rodder K, Bodnar Y, Pasqual-Melo G, Emmert S, Griguer CE, Weltmann KD, Bekeschus S. Cytochrome c oxidase inhibition and cold plasma-derived oxidants synergize in melanoma cell death induction. Sci Rep. 2018 Aug 24;8(1):12734.
-
Mallick A, More P, Syed MM, Basu S. Nanoparticle-mediated mitochondrial damage induces apoptosis in cancer. ACS Appl Mater Interf. 2016 May 18;8(21):13218-31.
-
Quayle LA, Pereira MG, Scheper G, Wiltshire T, Peake RE, Hussain I, Rea CA, Bates TE. Anti-angiogenic drugs: direct anti-cancer agents with mitochondrial mechanisms of action. Oncotarget. 2017 Oct 24;8(51):88670.
-
Hseu YC, Thiyagarajan V, Ou TT, Yang HL. CoQ 0-induced mitochondrial PTP opening triggers apoptosis via ROS-mediated VDAC1 upregulation in HL-60 leukemia cells and suppresses tumor growth in athymic nude mice/xenografted nude mice. Arch Toxicol. 2018 Jan 1;92(1):301-22.
-
Kadenbach B. Regulation of mitochondrial respiration and ATP synthesis via cytochrome c oxidase. Rendiconti Lincei. Scienze Fisiche Naturali. 2018 Jun 1;29(2):421-35.
-
Heng J, Guo X, Wu W, Wang Y, Li G, Chen M, Peng L, Wang S, Dai L, Tang L, Wang J. Integrated analysis of promoter mutation, methylation and expression of AKT1 gene in Chinese breast cancer patients. PLoS One. 2017 Mar 16;12(3):e0174022.
-
Gong H, Cao Y, Han G, Zhang Y, You Q, Wang Y, Pan Y. p53/microRNA-374b/AKT1 regulates colorectal cancer cell apoptosis in response to DNA damage. Int J Oncol. 2017 May 1;50(5):1785-91.
-
Vo TT, Park JH, Seo JH, Lee EJ, Choi H, Bae SJ, Le H, An S, Lee HS, Wee HJ, Kim KW. ARD1-mediated aurora kinase A acetylation promotes cell proliferation and migration. Oncotarget. 2017 Aug 22;8(34):57216.
-
Zou J, Zhang W, Li XL. Effects of SOST gene silencing on proliferation, apoptosis, invasion, and migration of human osteosarcoma cells through the Wnt/p-catenin signaling pathway. Calcif Tissue Int. 2017 Jun 1;100(6):551-64.
-
Scalcon V, Bindoli A, Rigobello MP. Significance of the mitochondrial thioredoxin reductase in cancer cells: an update on role, targets and inhibitors. Free Radl Biol Med. 2018 Nov 1;127:62-79.
-
Fan XY, Liu YJ, Chen K, Jiang FL, Hu YJ, Liu D, Liu Y, Ge YS. Organic arsenicals target thioredoxin reductase followed by oxidative stress and mitochondrial dysfunction resulting in apoptosis. Eur J Med Chem. 2018 Jan 1;143:1090-102.
-
Cassidy PB, Honeggar M, Poerschke RL, White K, Florell SR, Andtbacka RH, Tross J, Anderson M, Leachman SA, Moos PJ. The role of thioredoxin reductase 1 in melanoma metabolism and metastasis. Pigment Cell Melanoma Res. 2015 Nov;28(6):685-95.